TriangleNCT00392327 · OUTCOME
Percent Probability of Overall Survival (OS) for Patients With Medulloblastoma
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Percent Probability
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- Up to 5 years
What was measured
The Kaplan-Meier method will be used to estimate 5-year OS, defined as the time from study enrollment to death from any cause, or to date of last contact. Estimates are reported with 95% confidence intervals. Data below represents all molecular subgroups combined.
Analysis population: Eligible medulloblastoma patients are included.
Groups in this outcome
Regimen A (Medulloblastoma Patients)
Medulloblastoma patients who received regimen A (no carboplatin / no isotretinoin)
Regimen B (Medulloblastoma Patients)
Medulloblastoma patients who received regimen B (carboplatin / no isotretinoin)
Regimen C (Medulloblastoma Patients)
Medulloblastoma patients who received regimen C (no carboplatin / isotretinoin)
Regimen D (Medulloblastoma Patients)
Medulloblastoma patients who received regimen D (carboplatin / isotretinoin)
| Group | Source count |
|---|---|
| Regimen A (Medulloblastoma Patients) | 87 |
| Regimen B (Medulloblastoma Patients) | 89 |
| Regimen C (Medulloblastoma Patients) | 53 |
| Regimen D (Medulloblastoma Patients) | 56 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Regimen A (Medulloblastoma Patients) | 66.0 | Not reported | 52.7 | 79.3 | Not reported |
| Regimen B (Medulloblastoma Patients) | 75.9 | Not reported | 64.1 | 87.7 | Not reported |
| Regimen C (Medulloblastoma Patients) | 69.9 | Not reported | 57.1 | 82.1 | Not reported |
| Regimen D (Medulloblastoma Patients) | 81.6 | Not reported | 70.8 | 92.4 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 52.7
- upper Limit
- 79.3
- value
- 66.0
- group Id
- OG001
- lower Limit
- 64.1
- upper Limit
- 87.7
- value
- 75.9
- group Id
- OG002
- lower Limit
- 57.1
- upper Limit
- 82.1
- value
- 69.9
- group Id
- OG003
- lower Limit
- 70.8
- upper Limit
- 92.4
- value
- 81.6
- denoms
- counts
- group Id
- OG000
- value
- 87
- group Id
- OG001
- value
- 89
- group Id
- OG002
- value
- 53
- group Id
- OG003
- value
- 56
- units
- Participants
- description
- The Kaplan-Meier method will be used to estimate 5-year OS, defined as the time from study enrollment to death from any cause, or to date of last contact. Estimates are reported with 95% confidence intervals. Data below represents all molecular subgroups combined.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Medulloblastoma patients who received regimen A (no carboplatin / no isotretinoin)
- id
- OG000
- title
- Regimen A (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen B (carboplatin / no isotretinoin)
- id
- OG001
- title
- Regimen B (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen C (no carboplatin / isotretinoin)
- id
- OG002
- title
- Regimen C (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen D (carboplatin / isotretinoin)
- id
- OG003
- title
- Regimen D (Medulloblastoma Patients)
- param Type
- NUMBER
- population Description
- Eligible medulloblastoma patients are included.
- reporting Status
- POSTED
- time Frame
- Up to 5 years
- title
- Percent Probability of Overall Survival (OS) for Patients With Medulloblastoma
- type
- SECONDARY
- unit Of Measure
- Percent Probability
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice